ES2188924T3 - Procedimiento para generar imagenes por resonancia magnetica en ponderacion t1 para los organos del sre. - Google Patents
Procedimiento para generar imagenes por resonancia magnetica en ponderacion t1 para los organos del sre.Info
- Publication number
- ES2188924T3 ES2188924T3 ES97914482T ES97914482T ES2188924T3 ES 2188924 T3 ES2188924 T3 ES 2188924T3 ES 97914482 T ES97914482 T ES 97914482T ES 97914482 T ES97914482 T ES 97914482T ES 2188924 T3 ES2188924 T3 ES 2188924T3
- Authority
- ES
- Spain
- Prior art keywords
- magnetic resonance
- contrast
- sre
- weighting
- organs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
- A61K49/186—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA the organic macromolecular compound being polyethyleneglycol [PEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA, INVENCION PROPORCIONA UN METODO DE UNA ANGIOGRAFIA MR DE CONTRASTE MEJORADA DEL CUERPO DE SERES HUMANOS Y NO HUMANOS, INCLUYENDO DICHO METODO LA ADMINISTRACION EN LA VASCULATURA DEL MISMO UNA CANTIDAD EFECTIVA DE CONTRASTE DE UNA COMPOSICION DE AGENTE DE CONTRASTE QUE INCLUYE PARTICULAS MAGNETICAS CON RELACION R 1 /R 2 DE NO MAS DE 5 Y, EN EL MOMENTO EN Q UE UNA CANTIDAD SUFICIENTE DE DICHAS PARTICULAS MAGNETICAS PERMANECEN EN EL SISTEMA VASCULAR, PROPORCIONAR UNA MEJORA DEL CONTRASTE POSITIVO DEL MISMO EN UNA IMAGEN T 1 PONDERADA, AL TIEMPO QUE SE HAN INCORPORADOSUFICIENTES PARTICULAS MAGNETICAS EN UN ORGANO DEL SISTEMA RETICULOENDOTELIAL PARA PROPORCIONAR UNA MEJORA DEL CONTRASTE NEGATIVO DEL MISMO EN LA CITADA IMAGEN T 1 PONDERADA, GENERANDO UNA IMAGEN DE RESONANCIA MAGNETICA DE IMAGEN T 1 PONDERADA DE AL MENOS DICHO ORGANO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/625,223 US5855868A (en) | 1996-04-01 | 1996-04-01 | Method of T1 -weighted resonance imaging of RES organs |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188924T3 true ES2188924T3 (es) | 2003-07-01 |
Family
ID=24505090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97914482T Expired - Lifetime ES2188924T3 (es) | 1996-04-01 | 1997-03-27 | Procedimiento para generar imagenes por resonancia magnetica en ponderacion t1 para los organos del sre. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5855868A (es) |
EP (1) | EP0896546B1 (es) |
JP (1) | JP4361970B2 (es) |
KR (1) | KR20000005194A (es) |
CN (1) | CN1219135A (es) |
AT (1) | ATE228017T1 (es) |
AU (1) | AU704926B2 (es) |
CA (1) | CA2250818A1 (es) |
DE (1) | DE69717269T2 (es) |
EA (1) | EA000796B1 (es) |
ES (1) | ES2188924T3 (es) |
IL (1) | IL126412A0 (es) |
NO (1) | NO984555L (es) |
WO (1) | WO1997036617A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT81498B (pt) * | 1984-11-23 | 1987-12-30 | Schering Ag | Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas |
NZ333962A (en) * | 1996-08-05 | 2000-07-28 | Schering Ag | Process and device for the production of contrast media for magnetic resonance tomography |
WO2001074245A1 (en) * | 2000-03-31 | 2001-10-11 | Amersham Health As | Method of magnetic resonance imaging |
US7082326B2 (en) * | 2000-03-31 | 2006-07-25 | Amersham Health As | Method of magnetic resonance imaging |
KR20020075513A (ko) * | 2001-03-24 | 2002-10-05 | 조용덕 | 전기분해법을 이용한 폐수의 처리방법 |
DE102004022061A1 (de) * | 2004-05-05 | 2005-12-08 | Siemens Ag | Verfahren zur verbesserten interventionallen Bildgebung in der Magnet-Resonanz-Tomographie |
US20100259259A1 (en) * | 2005-09-21 | 2010-10-14 | Markus Zahn | Systems and methods for tuning properties of nanoparticles |
KR20090038337A (ko) * | 2007-10-15 | 2009-04-20 | 재단법인서울대학교산학협력재단 | 무기계 나노입자를 수계 매질에 분산시키는 생체적합성분산 안정화제 |
US10814019B2 (en) * | 2014-06-30 | 2020-10-27 | University Of Washington | MRI signal suppression agents, compositions, and methods |
WO2016187052A1 (en) * | 2015-05-15 | 2016-11-24 | Stc.Unm | Quantitative [fe]-mri (femri) of anti-psma-conjugated spions based on psma expression levels |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3935187A (en) * | 1973-10-19 | 1976-01-27 | Standard Brands Incorporated | Process for depolymerizing amylaceous polymers |
EP0093757A1 (en) * | 1981-11-12 | 1983-11-16 | Ulf SCHRÖDER | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
GB8408127D0 (en) * | 1984-03-29 | 1984-05-10 | Nyegaard & Co As | Contrast agents |
US4767611A (en) * | 1984-07-03 | 1988-08-30 | Gordon Robert T | Method for affecting intracellular and extracellular electric and magnetic dipoles |
US4849210A (en) * | 1985-05-08 | 1989-07-18 | Molecular Biosystems, Inc. | Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents |
GB8601100D0 (en) * | 1986-01-17 | 1986-02-19 | Cosmas Damian Ltd | Drug delivery system |
US4827945A (en) * | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US5314679A (en) * | 1986-07-03 | 1994-05-24 | Advanced Magnetics Inc. | Vascular magnetic resonance imaging agent comprising nanoparticles |
US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
US4925678A (en) * | 1987-04-01 | 1990-05-15 | Ranney David F | Endothelial envelopment drug carriers |
DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
US5358702A (en) * | 1990-04-10 | 1994-10-25 | Unger Evan C | Methoxylated gel particle contrast media for improved diagnostic imaging |
AU652804B2 (en) * | 1991-01-19 | 1994-09-08 | Meito Sangyo Kabushiki Kaisha | Composition containing ultrafine particles of magnetic metal oxide |
US5225282A (en) * | 1991-12-13 | 1993-07-06 | Molecular Bioquest, Inc. | Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer |
EP0580878B1 (en) * | 1992-06-01 | 1996-01-10 | BASF Aktiengesellschaft | The use of dispersions of magneto-ionic particles as MRI contrast media |
US5349957A (en) * | 1992-12-02 | 1994-09-27 | Sterling Winthrop Inc. | Preparation and magnetic properties of very small magnetite-dextran particles |
DE59403734D1 (de) * | 1993-03-17 | 1997-09-18 | Silica Gel Gmbh | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
DE4428851C2 (de) * | 1994-08-04 | 2000-05-04 | Diagnostikforschung Inst | Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie |
DK0783325T3 (da) * | 1994-09-27 | 2000-05-01 | Nycomed Imaging As | Kontrastmiddel |
ATE291439T1 (de) * | 1996-01-10 | 2005-04-15 | Amersham Health As | Kontrastmittel |
-
1996
- 1996-04-01 US US08/625,223 patent/US5855868A/en not_active Expired - Lifetime
-
1997
- 1997-03-27 KR KR1019980707869A patent/KR20000005194A/ko not_active Application Discontinuation
- 1997-03-27 EP EP97914482A patent/EP0896546B1/en not_active Expired - Lifetime
- 1997-03-27 JP JP53503697A patent/JP4361970B2/ja not_active Expired - Lifetime
- 1997-03-27 AU AU21721/97A patent/AU704926B2/en not_active Ceased
- 1997-03-27 CN CN97194760A patent/CN1219135A/zh active Pending
- 1997-03-27 IL IL12641297A patent/IL126412A0/xx unknown
- 1997-03-27 AT AT97914482T patent/ATE228017T1/de not_active IP Right Cessation
- 1997-03-27 EA EA199800881A patent/EA000796B1/ru not_active IP Right Cessation
- 1997-03-27 WO PCT/GB1997/000886 patent/WO1997036617A2/en not_active Application Discontinuation
- 1997-03-27 CA CA002250818A patent/CA2250818A1/en not_active Abandoned
- 1997-03-27 ES ES97914482T patent/ES2188924T3/es not_active Expired - Lifetime
- 1997-03-27 DE DE69717269T patent/DE69717269T2/de not_active Expired - Lifetime
-
1998
- 1998-09-29 NO NO984555A patent/NO984555L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5855868A (en) | 1999-01-05 |
WO1997036617A2 (en) | 1997-10-09 |
JP2000507567A (ja) | 2000-06-20 |
IL126412A0 (en) | 1999-05-09 |
EA199800881A1 (ru) | 1999-04-29 |
CN1219135A (zh) | 1999-06-09 |
EA000796B1 (ru) | 2000-04-24 |
CA2250818A1 (en) | 1997-10-09 |
AU704926B2 (en) | 1999-05-06 |
NO984555D0 (no) | 1998-09-29 |
EP0896546B1 (en) | 2002-11-20 |
DE69717269T2 (de) | 2003-08-28 |
KR20000005194A (ko) | 2000-01-25 |
AU2172197A (en) | 1997-10-22 |
JP4361970B2 (ja) | 2009-11-11 |
ATE228017T1 (de) | 2002-12-15 |
EP0896546A2 (en) | 1999-02-17 |
DE69717269D1 (de) | 2003-01-02 |
NO984555L (no) | 1998-09-29 |
WO1997036617A3 (en) | 1998-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE142891T1 (de) | Vaskulares magnetisches bildformungsverfahren | |
ES2116600T3 (es) | Metodos y composiciones para mejorar el contraste de imagenes. | |
FI953124A (fi) | Vesipitoiset ruiskutettavat formuloinnit, joita voidaan käyttää röntgentutkimuksiin, jotka käsittävät jodattuja aromaattisia yhdisteitä, joita käytetään kontrastiväliaineina röntgentutkimuksiin | |
ES2188924T3 (es) | Procedimiento para generar imagenes por resonancia magnetica en ponderacion t1 para los organos del sre. | |
NO854765L (no) | Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler. | |
DK0620743T3 (da) | Kontrastmidler bestående af galactosepartikler og en amfifil carboxylsyre | |
KR930700161A (ko) | 진단 작용제(Diagnostic Agents) | |
ATE99544T1 (de) | Liposomale radiologische kontrastmittel. | |
NO924481L (no) | Innkapslede partikler egnet som kontrastmidler i ultralyd- og roentgenavbildningssammensetninger og -fremgangsmaater | |
GB9716365D0 (en) | Improvements in or relating to magnetic resonance imaging | |
Mugel et al. | MR and CT findings in a case of hibernoma of the thigh extending into the pelvis | |
ES2117670T3 (es) | Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes. | |
Wallnoefer et al. | Comparison of 2D and 3D sequences for MRCP: Clinical value of the different techniques | |
EP0948361A4 (en) | MAGNETIC RESONANCE BLOOD POOL IMAGING AGENTS | |
DE60031973D1 (de) | Verfahren zur bilderzeugung durch magnetische resonanz | |
UA41932C2 (uk) | Засіб для ямр-томографії | |
Wasson et al. | Electrical potentials and tissue regeneration | |
Herborn et al. | MR imaging of atherosclerotic plaque with new ultrasmall particles of iron oxide (P7228) compared to Sinerem in hyperlipidemic rabbits | |
Fleury | ART. VI.--Cases of the Termination of Acute Rheumatism in Suppuration. | |
Helmy | Adult TMJ—Diabsmalleolar ligament—A fact or artifact | |
KR930700165A (ko) | 조영제 |